# 諾和諾德表示，自一月初推出以來，其Wegovy減重藥物處方已超過三百萬。

*biotech · news · 2026-06-08 · MarketScreener*

## Key points

- Wegovy減重藥物自一月在美國上市以來，處方數已超過三百萬。
- 超過80%的新Wegovy用戶是首次使用GLP-1藥物類別。
- 諾和諾德已在阿聯酋推出Wegovy藥物，並計劃今年進一步國際上市。
- 諾和諾德推出Wegovy HD，含7.2毫克司美格魯肽注射劑，為目前最高劑量的Wegovy。

By Dominic Chopping Novo Nordisk said prescriptions for its Wegovy weight-loss pill have surpassed three million since launching in early January. The Danish drugmaker said late Sunday that the pill hit one million prescriptions 12 weeks after reaching U.S. pharmacies and online providers, with a further two million prescriptions achieved in the following 10 weeks. More than 80% of new prescriptions filled for the Wegovy pill are for patients new to the GLP-1 class of drugs, which the company says indicates that the new oral formulation is expanding the obesity treatment market, rather than replacing existing injectable therapies. Having initially launched the Wegovy pill in the U.S., Novo Nordisk last week announced the drug's launch in the United Arab Emirates and it said it is preparing further launches in the second half of the year. The drugmaker has also recently launched a higher-dose Wegovy weight-loss shot, and it said the drug has also demonstrated strong uptake in the early days of availability. Wegovy HD is a once-weekly injection that contains 7.2 milligrams of active ingredient semaglutide, which the company has said offers the highest weight-loss of any Wegovy injection so far. Prior to the launch of Wegovy HD, the highest available injectable dose was 2.4 milligrams of semaglutide. Write to Dominic Chopping at dominic.chopping@wsj.com (END) Dow Jones Newswires 06-08-26 0233ET

**Companies:** Novo Nordisk
**Countries:** Denmark, United States, United Arab Emirates

[Read the full story on MarketScreener](https://www.marketscreener.com/news/novo-nordisk-weight-loss-pill-prescriptions-hit-three-million-since-launch-ce7f5dd2df8ffe20)

---

Canonical: https://newsio.io/zh-TW/n/1b00bbd8-1329-45cc-b203-57b594326d9e/wegovy12
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works